NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled
NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Recruiting36 enrolled